NCT02184091View on ClinicalTrials.gov

Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

July 31, 1999

Conditions
Renal InsufficiencyHepatic Insufficiency
Interventions
DRUG

Nevirapine

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184091 - Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine | Biotech Hunter | Biotech Hunter